LQCL2306 - CMLE - A 55-YEAR-OLD MAN WITH BILATERAL EXPIRATORY WHEEZING: CHALLENGES IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TESTING-A 55-YEAR-OLD MAN WITH BILATERAL EXPIRATORY WHEEZING: CHALLENGES IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TESTING

A 55-YEAR-OLD MAN WITH BILATERAL EXPIRATORY WHEEZING: CHALLENGES IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TESTING

Pdf Summary

The document discusses a case of a 55-year-old man presenting with symptoms suggestive of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The patient's history, symptoms, and laboratory findings are detailed, indicating the need for further testing for ANCA. The document delves into the challenges and importance of ANCA testing, different types of immunoassays used to detect ANCA, and the role of ANCA in the diagnosis and classification of AAV subtypes. It emphasizes the significance of testing for MPO-ANCA and PR3-ANCA using solid-phase immunoassays for accurate diagnosis and patient management.<br /><br />Furthermore, the document highlights the advancements in diagnostic tools and the importance of timely and accurate diagnosis of AAV to improve patient outcomes. It touches on the significance of dialog between the laboratory and clinicians for optimal patient care, along with the need for quality control measures to enhance testing performance.<br /><br />In conclusion, the document underscores the complexity of ANCA testing and the necessity of utilizing antigen-specific immunoassays as first-line tests for patients suspected of having AAV. It suggests that the use of MPO-ANCA and PR3-ANCA SPAs allows for better patient management and prognosis, emphasizing the need for individual laboratories to assess their testing strategies based on their patient population.

Keywords

Antineutrophil cytoplasmic antibody

ANCA-associated vasculitis

AAV

immunoassays

MPO-ANCA

PR3-ANCA

solid-phase immunoassays

diagnosis

patient management

laboratory-clinician dialogue